EPISODE · Jan 26, 2022 · 14 MIN
Andrea Garcia, JD, MPH, discusses the newest research on Omicron
from AMA Update · host American Medical Association
The webinar: "COVID-19: What to know about therapeutics and other treatment options" is scheduled for Tuesday, Feb. 1, at 3 p.m. Central time.Register and submit questions for the webinar here: https://www.ama-assn.org/delivering-care/public-health/covid-19-what-physicians-need-know-webinar-series
Embed this episode
What this episode covers
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH. Also covering the World Health Organization's (WHO) opinion on life post-Omicron, as well as newly published data from the CDC, JAMA, and what that research means in the battle against the current U.S. COVID surge. Additionally, the FDA has revised authorizations for two monoclonal antibody treatments—a topic AMA's immediate past-president, Susan Bailey, MD, will be discussing in an upcoming webinar with experts from the FDA.
NOW PLAYING
Andrea Garcia, JD, MPH, discusses the newest research on Omicron
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.